Introduction
============

Sepsis is a systemic inflammatory response syndrome (SIRS) caused by various factors, like endotoxin, exotoxin, virus or parasitic infection. With progression of the disease, inflammatory factors can activate a powerful immune response, or even immune dysregulation, thereby giving rise to dysfunction in organs and organic damage, in which acute lung damage is the most frequent event ([@b1-etm-0-0-5978]). At the initial stage of inflammation, tumor necrosis factor (TNF)-α is the first released pro-inflammatory factor, and the persistent increase in interleukin (IL)-1β and IL-6 indicates poor prognosis of SIRS ([@b2-etm-0-0-5978]). Inflammatory responses at the late stage can activate the enormous secretion of high mobility group box 1 (HMGB1) in lung tissues by mononuclear macrophages ([@b3-etm-0-0-5978]). In recent years, procalcitonin (PCT) serves as an indicator with a high value in monitoring sepsis in clinical practice ([@b4-etm-0-0-5978]). The aim of the present study was to explore a new method for diagnosis and treatment of sepsis in clinical practice through observing the effects of cisatracurium in combination with ventilation on expression of the above inflammatory factors and variations in cellular immunity in sepsis rats.

Materials and methods
=====================

### Experiment animals

A total of 54 healthy Sprague-Dawley male rats (10--14 weeks old) weighing between 250 and 300 g were purchased from the Shanghai SIPPR-Bk Lab Animal Co., Ltd. (Shanghai, China). The rats were housed in a temperature controlled room (21±2°C) on a 12-h light/dark cycle, with lights coming on at 06:00 a.m. All rats had free access to water and food. Facilities housing the animals were AAALAC-accredited at the time of the study. This study was approved by the Animal Ethics Committee of The First People\'s Hospital of Huzhou Animal Center (Huzhou, China).

### Modeling methods and experimental grouping

Sepsis models were prepared using cecal ligation and puncture (CLP) method ([@b5-etm-0-0-5978]). According to the random digit principle, rats were divided into three groups, i.e. sham group (n=6), model group (n=24) and experiment group (n=24). Animals were prepared for experiment after 12 h of fasting. For rats in sham group, they underwent laparotomy, while those in experiment group and model group were used for model establishment through CLP methods followed by symptomatic support with normal saline. After surgery, symptoms, including decreased activities, somnolence, dyspnea and other symptoms, appeared in sequence suggested that models were successfully established. Meanwhile, rats in the experiment group received cisatracurium treatment and tracheotomy for mechanical ventilation using the AVEA ventilator (Vyaire Medical, Mettawa, IL, USA).

### Detection indexes

At 6, 12 and 24 h after CLP, animals were anesthetized by pentobarbital sodium, respectively, and at each time-point, 6 animals were treated for blood collection through abdominal aorta followed by isolation of serum. Using a Synergy H1 microplate reader (BioTek Instruments, Inc., Winooski, VT, USA), levels of TNF-α, IL-1β, IL-6 and PCT were detected in serum at different time-points; 24 h later, HMGB1 expression and wet/dry (W/D) ratio of lung tissues were determined. Thereafter, T lymphocyte subsets, cluster of differentiation (CD) 4^+^ and CD8^+^ in serum were detected using the Attune Flow Cytometer (Applied Biosystems, Foster City, CA, USA). Ratio of leukocyte to neutrophil in peripheral blood was also measured using 7600 Automatic Biochemical Analyzer (Hitachi, Tokyo, Japan). FinePointe™ NAM Non-invasive Pulmonary Function Analyzer for Animals (Buxco, Troy, NY, USA) was used to detect the values of forced expiratory volume in one second (FEV~1~), FEV~1~/forced vital capacity (FVC) and FEV~1~% (percent of FEV~1~ in expected value).

### Statistical analysis

Data analysis was carried out using SPSS 19.0 software (IBM, Armonk, NY, USA). Measurement data were presented as mean ± standard deviation, t-test was performed for pairwise comparison and analysis of variance was carried out for multi-group comparison. Pearson\'s correlation analysis was adopted for correlation analysis. A P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparisons of levels of inflammatory factors in serum at different time-points

The results of this study indicated that the levels of TNF-α, IL-1β, IL-6 and PCT in serum at 6 h after the model establishment in the model group were significantly higher than those in sham group. Significant differences were identified in comparisons of the levels of TNF-α, IL-6 and PCT in serum at 6, 12 and 24 h between experiment group and model group (P\<0.01, or P\<0.05), and comparisons of IL-1β level in serum at 6 and 12 h between two groups also showed statistically significant differences (P\<0.01 or P\<0.05; [Table I](#tI-etm-0-0-5978){ref-type="table"}).

### Expression of HMGB1 (inflammatory mediator in the late stage) and W/D ratio of lung tissues

At 24 h, expression of HMGB1 and W/D ratio of lung tissues were determined, and the results revealed that the level of HMGB1 and W/D ratio in model group were significantly higher than those in sham group; at 24 h after CLP, HMGB1 levels and W/D ratio of experiment group and model group was 59±34 vs. 118±21 pg/ml and 4.6±0.4 vs. 6.5±0.5, respectively, indicating that treatment can alleviate the inflammatory status in lung of sepsis rats ([Table II](#tII-etm-0-0-5978){ref-type="table"}).

### Comparison of the levels of T lymphocyte subsets at 24 h

In this study, the results indicated that the indicator levels of T lymphocyte subsets in rats of model group at 24 h after CLP were significantly lower than those in sham group, and the portions of CD4^+^ and CD8^+^ as well as CD4^+^/CD8^+^ ratios in experiment group and model group were 39.98±3.37 vs. 27.35±4.01%, 27.17±4.22 vs. 21.81±3.26% and 1.42±0.29 vs. 1.13±0.05 pg/ml, respectively, suggesting that the immune functions of sepsis rats are ameliorated after treatment (P\<0.01, or P\<0.05; [Table III](#tIII-etm-0-0-5978){ref-type="table"}).

### Comparison of the indicators for pulmonary functions

Results of this study suggested that at 24 h after model establishment, indicator levels for pulmonary functions of rats in model group were significantly lower than those in sham group, while the values of FEV~1~, FEV~1~/FVC and FEV~1~% at 6, 12 and 24 h after CLP in model group were significantly lower than those in the experiment group, and the differences had statistical significance (P\<0.01 or P\<0.05; [Table IV](#tIV-etm-0-0-5978){ref-type="table"}).

### Correlation analysis between inflammatory factors in serum and pulmonary functions in sepsis

According to Pearson\'s correlation analysis, levels of TNF-α, IL-6 and PCT in sepsis were negatively correlated with the indicators for pulmonary functions, FEV~1~, FEV~1~/FVC and FEV~1~ (%), and the correlation had statistical significance (P\<0.05), suggesting that the level of inflammatory factors is directly correlated with the pulmonary function status ([Table V](#tV-etm-0-0-5978){ref-type="table"}).

### Comparison of the ratio of leukocytes to neutrophils in peripheral blood of animals

The results of this study indicated that at 6 h after model establishment, ratio of leukocytes to neutrophils in peripheral blood in rats of model group was significantly higher than that in sham group, while after treatment, ratios in experiment group at different time-points were all higher than those in the model group (P\<0.01; [Table VI](#tVI-etm-0-0-5978){ref-type="table"}).

Discussion
==========

The major pathophysiological mechanism accounting for the development and progression of sepsis lies in the dysregulation of dynamic balance between inflammatory mediators and anti-inflammatory factors in SIRS ([@b6-etm-0-0-5978]). Infection, without timely treatment, usually leads to severe persistent hypotension, and affects the physiological functions of multiple organs in the body, contributing to the septic shock and multiple organ dysfunction syndrome (MODS) that lead to death of almost 80% of sepsis patients ([@b7-etm-0-0-5978],[@b8-etm-0-0-5978]).

In the network of inflammatory cytokines, TNF-α is released first, and can activate downstream signal transduction pathway to induce the secretion of inflammatory cytokines (IL-1β and IL-6) through binding with the receptors, and inhibit the generation of anti-inflammatory factors, thereby giving rise to waterfall-like cascade reactions of inflammation ([@b9-etm-0-0-5978]). Sepsis is always accompaned by an acute increase in PCT. Generally, within 3 or 4 h after infection, PCT can be detected in the body, and peak level is usually attained within 8 to 24 h. It has been confirmed that PCT can serve as an effective indicator for diagnosis of infection in critical patients to monitor the variations in conditions of sepsis, and an elevation in PCT can be identified in severe systemic infection and septic shock ([@b10-etm-0-0-5978]). Deng *et al* ([@b11-etm-0-0-5978]) proved that HMGB1 can induce the generation of inflammatory cytokines through activating the macrophages, thereby leading to the onset of acute lung injury (ALI). Bone, an American scholar, put forward the hypothesis of compensatory anti-inflammatory response syndrome ([@b12-etm-0-0-5978]), in which it was proposed that the imbalance between pro- and anti-inflammation mechanism leads to the development of sepsis, and to a certain degree, T lymphocyte subsets can induce the corresponding reactions specifically for the status of cellular immunity. In progression of SIRS, the role of immune system has also become a hotspot in clinical and fundamental research ([@b13-etm-0-0-5978],[@b14-etm-0-0-5978]). CD4^+^T and CD8^+^T are featured with the functions of antibody generation, activation of macrophages and regulation of cellular immunity. It is reported that a decrease in CD4^+^T/CD8^+^T ratio indicates that sepsis has evolved into a severe phage and the prognosis is poor ([@b15-etm-0-0-5978]). In clinical practice, mechanical ventilation has been usually considered to increase the oxygenation capacity, thereby ameliorating the pulmonary ventilation function and alleviating the inflammatory responses. Non-depolarizing muscle relaxants (atracurium as a common non-depolarizing muscle relaxant in clinical practice), major adjuvant drugs in mechanical ventilation of sepsis patients, can alleviate the inflammatory responses in airways ([@b16-etm-0-0-5978]). Narimatsu *et al* ([@b17-etm-0-0-5978]) reported that affected by the inflammatory mediation, *in vivo* expression of acetylcholine receptors in sepsis patients shows poor sensitivity to non-depolarizing muscle relaxant, leading to neuromuscular dysfunction, delay in initiation of effect and shortness of drug action. Cisatracurium is one of the geometric isomers, and according to the pharmacodynamics studies, its effect on muscular relaxation is almost three times that of atracurium ([@b18-etm-0-0-5978]). It is also reported that the other prominent feature of cisatracurium is rapid onset and metabolism but without release of histamine, a major endogenous active substance in allergic reaction ([@b19-etm-0-0-5978],[@b20-etm-0-0-5978]).

Results of this study indicated that at 6 h after the model establishment, levels of inflammatory factors in the model and the experiment groups were significantly higher than those in the sham group, suggested that models were successfully established. At 6, 12 and 24 h after treatment, decline was detected in levels of inflammatory factors, including TNF-α, IL-6 and PCT in the experiment group, which was significantly lower than those in model group at the same time-point. At 6 and 12 h, differences in levels of IL-1β between two groups had statistical significance (P\<0.01 or P\<0.05). At 24 h, measurements of expression of HMGB1 and W/D ratio of lung tissues indicated: The level of HMGB1 and W/D ratio in model group was significantly higher than those in sham group; at 24 h after CLP, HMGB1 levels and W/D ratio in experiment group and model group was 59±34 vs. 118±21 pg/ml and 4.6±0.4 vs. 6.5±0.5, respectively, suggesting that treatment can alleviate the pulmonary inflammation to a certain extent. Portions of CD4^+^ and CD8^+^ as well as CD4^+^/CD8^+^ ratio in experiment group and model group was 39.98±3.37 vs. 27.35±4.01%, 27.17±4.22 vs. 21.81±3.26%, and 1.42±0.29 vs. 1.13±0.05 pg/ml, respectively, suggesting that the immune functions of sepsis rats are ameliorated after treatment (P\<0.01, or P\<0.05). In addition, according to Pearson\'s correlation analysis, levels of TNF-α, IL-6 and PCT in sepsis were negatively correlated with the indicators for pulmonary functions, FEV~1~, FEV~1~/FVC and FEV~1~ (%), and the correlation had statistical significance (P\<0.05), suggesting that the level of inflammatory factors is directly correlated with the pulmonary function status. After treatment, the count of leukocytes and its ratio to neutrophils in peripheral blood in the experiment group at different time-points were all higher than those in the model group. Thus, this study confirmed that cisatracurium in combination with ventilation can increase the cellular immune functions and combat the inhibitory effect on immune system produced in sepsis, but the specific mechanism requires further studies.

In conclusion, cisatracurium in combination with ventilation can alleviate the inflammatory injury to organs in sepsis rats through inhibiting the inflammatory responses and regulating the immune functions, which manifests a new significance in guiding the clinical diagnosis and treatment.
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###### 

Comparison of the levels of inflammatory factors in serum at different time-points among three groups (mean ± SD).

  Groups       Case   Time-point (h)   TNF-α (pg/ml)                                              IL-1β (pg/ml)                                              IL-6 (pg/ml)                                               PCT (ng/l)
  ------------ ------ ---------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------
  Sham         6                       19.62±6.37                                                 17.96±4.98                                                 22.25±2.58                                                 48.31±2.14
  Model        8      6                65.49±4.55^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   36.31±6.57^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   69.04±3.09^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   368.45±29.66^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^
               8      12               47.55±3.47^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   31.12±5.16^[a](#tfn1-etm-0-0-5978){ref-type="table-fn"}^   83.68±3.24^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   359.84±28.34^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^
               8      24               30.93±3.61^[a](#tfn1-etm-0-0-5978){ref-type="table-fn"}^   24.01±6.85                                                 66.35±5.13^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^   377.00±26.65^[b](#tfn2-etm-0-0-5978){ref-type="table-fn"}^
  Experiment   8      6                36.74±5.37^[d](#tfn4-etm-0-0-5978){ref-type="table-fn"}^   26.82±6.48^[d](#tfn4-etm-0-0-5978){ref-type="table-fn"}^   52.87±4.54^[d](#tfn4-etm-0-0-5978){ref-type="table-fn"}^   231.33±31.45^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^
               8      12               26.78±5.70^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^   22.01±4.78^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^   64.77±3.69^[d](#tfn4-etm-0-0-5978){ref-type="table-fn"}^   219.47±32.21^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^
               8      24               20.83±2.96^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^   20.88±6.02                                                 50.47±6.95^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^   199.45±35.13^[c](#tfn3-etm-0-0-5978){ref-type="table-fn"}^

P\<0.05, or

P\<0.01 compared with sham group

P\<0.05, or

P\<0.01 compared with model group. TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1beta; IL-6, interleukin-6; PCT, procalcitonin; SD, standard deviation.

###### 

Comparison of HMGB1 levels and W/D ratios of lung tissues among three groups at 24 h (mean ± SD).

  Detection indicators        Case   Sham group   Model group                                             Experiment group
  --------------------------- ------ ------------ ------------------------------------------------------- -------------------------------------------------------
  HMGB1 (pg/ml)               8      41±36        118±21^[a](#tfn5-etm-0-0-5978){ref-type="table-fn"}^    59±34^[b](#tfn6-etm-0-0-5978){ref-type="table-fn"}^
  W/D ratio of lung tissues   8      4.2±0.6      6.5±0.5^[a](#tfn5-etm-0-0-5978){ref-type="table-fn"}^   4.6±0.4^[b](#tfn6-etm-0-0-5978){ref-type="table-fn"}^

P\<0.01 compared with sham group

P\<0.05 compared with model group. HMGB1, high mobility group box 1; W/D, wet/dry; SD, standard deviation.

###### 

Comparison of the levels of T lymphocyte subsets at 24 h among groups (mean ± SD).

  Groups       Case   CD4^+^ (%)                                                 CD8^+^ (%)                                                 CD4^+^/CD8^+^
  ------------ ------ ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------
  Sham         6      51.71±4.42                                                 29.80±3.75                                                 1.69±0.39
  Model        8      27.35±4.01^[a](#tfn7-etm-0-0-5978){ref-type="table-fn"}^   21.81±3.26^[a](#tfn7-etm-0-0-5978){ref-type="table-fn"}^   1.13±0.05^[a](#tfn7-etm-0-0-5978){ref-type="table-fn"}^
  Experiment   8      39.98±3.37^[c](#tfn9-etm-0-0-5978){ref-type="table-fn"}^   27.17±4.22^[b](#tfn8-etm-0-0-5978){ref-type="table-fn"}^   1.42±0.29^[b](#tfn8-etm-0-0-5978){ref-type="table-fn"}^

P\<0.01 compared with sham group

P\<0.05, or

P\<0.01 compared with model group; SD, standard deviation.

###### 

Comparison of the indicators for pulmonary functions among groups (mean ± SD).

  Groups       Case   Time-point (h)   FEV~1~ (l)                                                 FEV~1~/FVC (%)                                               FEV~1~ (%)
  ------------ ------ ---------------- ---------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------
  Sham         6                       1.66±0.51                                                  68.83±8.16                                                   70.45±7.89
  Model        8      6                1.14±0.54^[a](#tfn10-etm-0-0-5978){ref-type="table-fn"}^   52.69±10.11^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^   48.28±10.88^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^
               8      12               1.18±0.49^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^   53.36±9.51^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^    49.57±9.62^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^
               8      24               1.29±0.55^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^   55.12±9.16^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^    50.66±7.97^[b](#tfn11-etm-0-0-5978){ref-type="table-fn"}^
  Experiment   8      6                1.27±0.38^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^   56.78±9.25                                                   51.18±9.66^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^
               8      12               1.52±0.37^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^   60.15±10.01^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^   55.26±8.74^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^
               8      24               1.58±0.44^[c](#tfn12-etm-0-0-5978){ref-type="table-fn"}^   65.18±8.25^[d](#tfn13-etm-0-0-5978){ref-type="table-fn"}^    61.85±9.75^[d](#tfn13-etm-0-0-5978){ref-type="table-fn"}^

P\<0.05, or

P\<0.01 compared with sham group

P\<0.05, or

P\<0.01 compared with model group. FEV~1,~ forced expiratory volume in one second; FVC, forced vital capacity; SD, standard deviation.

###### 

Correlation analysis between inflammatory factors in serum and pulmonary functions in sepsis.

  Corresponding variable   vs. TNF-α (r)                                          vs. IL-1β (r)   vs. IL-6 (r)                                           vs. PCT (r)
  ------------------------ ------------------------------------------------------ --------------- ------------------------------------------------------ ------------------------------------------------------
  FEV~1~ (l)               −1.01^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.41           −0.79^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.85^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^
  FEV~1~/FVC (%)           −0.81^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.40           −0.68^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.79^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^
  FEV~1~ (%)               −0.90^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.31           −0.74^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^   −0.99^[a](#tfn14-etm-0-0-5978){ref-type="table-fn"}^

P\<0.05. FEV~1~, forced expiratory volume in one second; FVC, forced vital capacity; TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1beta; IL-6, interleukin-6; PCT, procalcitonin.

###### 

Comparison of the ratio of leukocyte to neutrophil in peripheral blood of animals among the groups (mean ± SD).

  Groups       Case   Time-point (h)   Count of leukocytes (×10^9^/l)                              Ratio of leukocytes to neutrophils (%)
  ------------ ------ ---------------- ----------------------------------------------------------- -----------------------------------------------------------
  Sham         6                       4.42±0.94                                                   63.11±0.23
  Model        8      6                11.91±1.32^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^   81.98±1.52^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^
               8      12               14.99±1.56^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^   89.81±2.14^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^
               8      24               13.21±1.42^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^   84.12±1.91^[a](#tfn15-etm-0-0-5978){ref-type="table-fn"}^
  Experiment   8      6                7.30±0.88^[b](#tfn16-etm-0-0-5978){ref-type="table-fn"}^    76.11±1.61^[b](#tfn16-etm-0-0-5978){ref-type="table-fn"}^
               8      12               6.43±1.02^[c](#tfn17-etm-0-0-5978){ref-type="table-fn"}^    73.87±1.44^[c](#tfn17-etm-0-0-5978){ref-type="table-fn"}^
               8      24               5.65±1.56^[c](#tfn17-etm-0-0-5978){ref-type="table-fn"}^    70.01±1.11^[c](#tfn17-etm-0-0-5978){ref-type="table-fn"}^

P\<0.01 compared with sham group

P\<0.05, or

P\<0.01 compared with model group. SD, standard deviation.
